Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 2014. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific share transaction rather than a financial performance report.
Material Changes
The material change disclosed is the acquisition of Ordinary Shares by a connected person:
- Transaction Date: April 9, 2014
- Share Price: 1,572.79 pence per Ordinary Share
- Connected Persons: Mr. P C Thomson and Mrs. K Thomson
- Acquisition Details:
- 8 Ordinary Shares acquired under the personal contribution element of the ShareReward Plan.
- 8 Ordinary Shares acquired under the matching element of the Plan (Company contribution).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the share purchase in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
Investor Verification Points
- Verify the total number of shares held by Mr. P C Thomson and Mrs. K Thomson following this transaction.
- Confirm the terms of the ShareReward Plan regarding personal contributions and company matching.
- Check for any other pending director or connected person transactions not yet filed.